Catalyst
Slingshot members are tracking this event:
Esperion plans to initiate the global pivotal Phase 3 CLEAR LDL-C lowering efficacy studies and the global CLEAR Outcomes trial in Q4 2016
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ESPR | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jan 09, 2017
Occurred Source:
http://investor.esperion.com/releasedetail.cfm?ReleaseID=1007085
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Clear Outcoes Trial, Clear Ldl-c
